Space Nord Invest (SPACEN) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
9 Oct, 2026Executive summary
Sold HifabGruppen and its operating subsidiaries to Vaaka Partners; sale completed 11 Aug 2026, leaving a cash-focused entity with no operating business.
Board proposed voluntary liquidation; estimated distribution is ~SEK 4.20 per share, subject to costs and the liquidation process.
Financial highlights
Jan–Sep 2026 revenue was SEK 1.1m, operating loss SEK 2.1m, disposal gain SEK 79.1m and net profit SEK 74.7m.
Net profit included a SEK 2.9m tax expense from writing down deferred tax assets; transaction costs were ~SEK 2m.
Cash and cash equivalents were SEK 253.6m at 30 Sep 2026, versus SEK 9.4m at 30 Sep 2025.
Outlook and guidance
Estimated liquidation distribution of ~SEK 4.20 per share is preliminary, based on ~SEK 254m net cash, estimated costs and interest income.
Voluntary liquidation is expected to take 7–8 months after registration of the shareholder resolution; timing depends on the six-month creditor notice period and may be delayed by unforeseen matters.
Nasdaq Stockholm intends to decide on delisting on 23 Nov 2026; last trading day is expected to be 7 Dec 2026, subject to change due to the proposed liquidation.
Latest events from Space Nord Invest
- Profitability rose and a major divestment was agreed, with strong cash flow and margins in H1 2026.SPACEN
Q2 2026 - Q1 2026 delivered higher revenue, margins, and cash flow, with a focus on profitable growth.SPACEN
Q1 2026 - Adjusted EBITA margin rose to 11.1% in 2025 amid lower revenue and strategic transformation.SPACEN
Q4 2025 - Profitability improved in Q3 as the group rebranded and positioned for future growth.SPACEN
Q3 2025 - Revenue and profit fell, but organic consulting growth and strong liquidity were maintained.SPACEN
Q2 2025 - Q3 saw higher sales and margins, with ongoing transformation and regional expansion.SPACEN
Q3 2024 - Q2 EBIT margin more than doubled to 8.3% on 8.4% organic growth, driven by advisory focus.SPACEN
Q2 2024 - Solid profitability and strong liquidity despite lower sales, with new contracts fueling optimism.SPACEN
Q1 2025 - Turnaround drives 2024 profit surge; Hifab targets >10% EBIT margin in 2025.SPACEN
Q4 2024